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Abstract
We report an unusual case of a 32-year old man who was treated for a hypertrophic obstructive
cardiomyopathy (HOCM) with a DDD pacing with short AV delay reduction in the past. Without
prior notice the patient developed ventricular fibrillation and an invasive cardiac diagnostic was
performed, which revealed a myocardial bridging around of the left anterior descending artery
(LAD). We suspected ischemia that could be either related to LAD artery compression or
perfusion abnormalities due to AV delay reduction with related to diastolic dysfunction.
Case report
We are reporting on a 32-year-old patient who had been
treated for a prolonged period of time for symptoms of
HOCM. However, the diagnosis of a flow acceleration and
pressure gradient in the outflow tract had only been made
by echocardiography (ECHO) up to that point. In 2004, a
2-chamber pacemaker with a short AV conduction time
(70 ms) was implanted for a left precordial repolarization
abnormality and to lower the pressure gradient between
the ventricle and outflow tract. Freedom from symptoms
was not actually achieved with this treatment. In February
of this year, the patient was found in a non-responsive
state following what had most likely been a period of
complete well-being. Emergency cardiovascular resuscita-
tion was not started immediatly, however, and the inter-
val before resuscitation was started was approximately 5
minutes. When the emergency medical services arrived,
the patient had no pulse of his own, while the pacemaker
continued to work. After a short period of cardiopulmo-
nary reanimation, a status of ventricular fibrillation was
reached. At this point, a single defibrillation of 200 joules
was applied and spontaneous circulation was established
once again. The patient was only taking inadequate gasp-
ing breaths; as a result, he was intubated immediately. A
low dose of adrenaline was administered due to hypot-
onic circulation; the patient then became hemodynami-
cally stable. Upon admission to our clinic, cerebral
imaging was immediately ordered; this showed no intrac-
erebral bleeding, ischemia or edema. Neuroprotective
hypothermia therapy was also immediately introduced
for a period of 48 hours. Echocardiography revealed
severe left ventricular hypertrophy with normal left ven-
tricular ejection fraction (EF > 60%) and normal dimen-
sions. Additionally, the ECHO exhibited nearly complete
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obstruction of the the left ventricular outflow tract
(LVOT) by the hypertrophied septum including a systolic
anterior motion phenomena (SAM) by the anterior leaflet
of the mitral valve.
The subsequently performed cardiac catheterization
revealed a non-typical obstruction involving the ventricle
in the ventriculography. There was also a subtotal muscle
bridge of the LAD (Fig. 1) leading to a virtually obstructive
systolic vascular pattern. After stabilizing all parameters,
the patient was finally transferred to our section for a sur-
gical myectomy for HOCM. The LAD was unroofed from
its myocardial bridge (Fig. 2). However, intraoperative
findings surprisingly showed a membranous subaortic
stenosis (Fig. 3) with consecutive left ventricular hypertro-
phy.
The patient survived the operation and his symptoms
were relieved. The postoperative course was uneventful
and postoperative coronary angiogram showed good res-
olution of the muscle bridge in the patient (Fig. 4).
Discussion
HOCM is a complex and heterogeneous disease of cardiac
muscle with a variety of functional, morphologic and clin-
ical manifestations and is associated with various clinical
presentations ranging from complete absence of symp-
toms to sudden, unexpected death. The overall prevalence
of hypertrophic cardiomyopathy (HCM) has been esti-
mated to average between 0.02% and 0.2% of the popula-
tion [1]. The established medical therapy for patients with
HOCM is a trial of large doses of beta-blockers, calcium
channel antagonists, or disopyramide, either alone or in
combination. Operation is a well established procedure
with more than 40 years of experience and has been the
gold standard therapy for those severely symptomatic
patients with fixed or inducible gradients who are intoler-
ant of these medications or unresponsive to them [2-6]. In
addition, alcohol septal ablation, well-accepted as a
potentially curative therapy for HOCM-patients refractory
Preoperative angiogram showing the appearance of the mus- cular bridge over the left anterior descending artery during  systole Figure 1
Preoperative angiogram showing the appearance of 
the muscular bridge over the left anterior descend-
ing artery during systole.
Intraoperative view during the reconstruction of LAD Figure 2
Intraoperative view during the reconstruction of 
LAD.
Excised subaortic membrane Figure 3
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to maximal medical therapy, is still considered innovative
and becomes widely accepted [7-10].
Additionally, permanent dual-chamber (DDD) pacing
has been proposed as an adjunct treatment to reduce
symptoms in markedly symptomatic patients with
HOCM [11,12]. Several early observational and uncon-
trolled studies have suggested that dual chamber pacing
has a benefit in patients with HOCM. The beneficial
effects were alteration of the myocardial activation
sequence inducing dyssynchronous ventricular activation
and paradoxical septal movement, negative inotropic
effects, and alteration of mitral valve leaflet excursion [13-
15]. However, there are numerous studies of dual cham-
ber pacing that have yielded conflicting results. These
studies have investigated the beneficieal effects of pacing
on gradient, pacing on gradient, symptoms, and quality of
life, but have failed to make a definitive statement con-
cerning the risk of sudden death at the present time.
Finally, it is well known that in patients with HOCM
supraventricular tachycardias are common and several
factors may make these patients susceptible to ventricular
fibrillation [15]. Furthermore, in our case the coronary
angiogram reveals a left anterior descending coronary
artery bridge. Myocardial bridging with compression of
epicardial vessels occurs in 30-50% of adults with HOCM
[16]. The role of myocardial bridging in ischemia and sud-
den death in patients with HOCM remains controversial
[17]. Regardless, a poorer outcome of HOCM combined
with bridging has been outlined [18].
Interestingly, the operation of our patient revealed a sub-
aortic obstruction in the form of subaortic membrane,
which has a congenital basis and is responsible for 8% to
20% of cases of congenital left ventricular outflow
obstruction (LVOT) [19]. In most instances, the lesion
progresses to produce LVOT obstruction during child-
hood and adolescence, while in some instances it does not
[20]. However, there is little information about this lesion
in adults.
Finally, it remains unclear what clinicopathological rea-
sons induced the sudden cardiac death. It is possible, that
the dual chamber pacing with AV delay reduction and/or
the left artery descending bridge induced ischemia which
leads to ventricular fibrillation with cardiopulmonary
resuscitation, otherwise it is also possible that only the
LVOT obstruction lead to ventricular defibrillation. The
benefit of ICD treatment has been been well established
among patients at high risk of sudden cardiac death in sec-
ondary and primary prevention seetings. However, in this
case the myocardial bridging and left ventrucular outflow
obstruction was surgically controlled. Therefore, we
renouced to implantate an ICD.
Thomson et al. have demonstrated the mechanisms of
myocardial ischemia in HOCM-patients with magnetic
resonance imaging (MRI). Possibly, this promising diag-
nostic option becomes routinely available for patients
with HOCM and signs of ischemia.
These patients are a technical challenge and should be
treated by very experienced surgeons, cardiologists, and
anaesthetists in specialized institutions.
Conclusion
On the basis on this case, dual chamber pacing can not
regarded as primary treatment modality for left ventricular
obstruction. For a select subset of patients with refractory
LVOT obstruction, DDD pacing with a short atrioventricu-
lar (AV) delay may be of benefit or represent a therapeutic
option for some elderly patients with HOCM, particularly
those who reject operation/alcohol septal ablation or do
not have access to experienced surgeon and cardiologists
in specialized institutions. However, short delay DDD-
pacing is obviously not acceptable in patients with an
obstructive subaortic membrane.
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Postoperative angiogram showing patent left anterior  descending artery during systole, after incision muscular  bridge and reconstruction Figure 4
Postoperative angiogram showing patent left ante-
rior descending artery during systole, after incision 
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